Submitted by Anonymous (not verified) on 7 November 2023 - 12:56
Human medicines European public assessment report (EPAR): Lacosamide UCB, lacosamide, Epilepsies, Partial, Date of authorisation: 26/08/2019, Revision: 6, Status: Authorised
Source:
